Nieves Purificacion
Martinez Lago
![Foto de Nieves Purificacion](/img/nophoto.png)
![Foto de Complexo Hospitalario Universitario de Pontevedra](/img/noimage_org.png)
Complexo Hospitalario Universitario de Pontevedra
Pontevedra, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Pontevedra (10)
2024
-
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON–SEOM registry
Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1674-1686
2023
-
Role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT): From biology to theragnosis
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 3, pp. 156-162
2021
-
Dynamic perspective of the neutrophil-to-lymphocyte ratio in metastatic gastric cancer
Journal of B.U.ON., Vol. 26, Núm. 5, pp. 2131-2140
-
Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain
BMC Cancer, Vol. 21, Núm. 1
-
Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data
Scientific Reports, Vol. 11, Núm. 1
-
Real-life use of ramucirumab in gastric cancer in Spain: The RAMIS study
Future Oncology, Vol. 17, Núm. 14, pp. 1777-1791
-
The role of intestinal microbiota in the colorectal carcinogenesis
Foundations of Colorectal Cancer (Elsevier), pp. 495-512
2020
-
Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram
Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 351-359
2019
-
Efficacy and safety of FOLFIRI/Aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after the failure of an oxaliplatin-based regimen
Annals of Oncology, Vol. 30, pp. iv42-iv43
-
Is there any affordable and reliable score in local gastric cancer?
Annals of Oncology, Vol. 30, pp. iv60